Leukoencephalopathy-causing CLCN2 mutations are associated with impaired Cl^- channel function and trafficking

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Leukodystrophies are a group of inherited neurological disorders affecting myelin.
• Mutations in CLCN2 are associated with leukodystrophy characterized by intramyelinic edema.
• The chloride channel ClC-2 plays a crucial role in glial cell function.

Purpose of the Study:

• To characterize CLCN2 mutations found in leukodystrophy patients.
• To investigate the functional impact of these mutations on the ClC-2 channel.
• To explore the role of GlialCAM and MLC1 in modulating ClC-2 function and stability.

Main Methods:

• Biochemical and electrophysiological analyses of CLCN2 mutations.
• Co-expression studies with GlialCAM and MLC1.
• Assessment of protein localization and turnover at the plasma membrane.

Main Results:

• Most CLCN2 mutations reduce ClC-2 channel function and impair its plasma membrane expression.
• The Ala500Val mutation in ClC-2 exhibits defective gating and increased turnover.
• GlialCAM and MLC1 rescue ClC-2 function by improving gating and stabilizing the channel at the plasma membrane, particularly at cell-cell junctions.

Conclusions:

• CLCN2 mutations causing leukodystrophy lead to reduced functional expression of the ClC-2 channel.
• GlialCAM and MLC1 can counteract these defects by enhancing ClC-2 gating and membrane stability.
• These findings highlight a potential therapeutic target for CLCN2-related leukodystrophies.